Description
Detect macular degeneration risk
Macular pigment monitoring with the MPS II
Now eye care professionals can take a proactive, preventative approach to the growing global problem of age-related macular degeneration (AMD).
Measuring macular pigment optical density (MPOD) – a significant and modifiable risk factor for AMD – the MPS II provides results at speeds as fast as 90 seconds per eye.
A proactive approach to a global issue
Added value for practitioners and patients
Age-related macular degeneration (AMD) is a growing global socioeconomic threat, but there are ways to prevent or mitigate its impact. By adopting a proactive approach to fighting the condition, eye care professionals can identify and help those most at risk before more serious intervention is necessary.
The Macular Pigment Screener (MPS II) is a key enabler in such an approach. It helps patients by identifying and monitoring macular pigment levels over time and supports professionals with the diversification of eye health services. It is:
| Reliable | → | scientifically validated through use in multiple studies |
| Repeatable | → | has accurately measured more than 4 million eyes |
| Intuitive | → | easy-to-use user interface with icon-driven menus |
| Fast | → | screen in 90 seconds per eye for efficient patient care |
| Commercially viable | → | clear ROI through test fees and supplement sales |
